COLLABORATE El Meu Clínic .This link opens in a new tab.
COLLABORATE El Meu Clínic .This link opens in a new tab.
Make a donation
Navigation thread
Navigation thread
Advanced imaging in neuroimmunological diseases (ImaginEM)
Make a donation

Featured projects

  • Phase I trial of ARI0001 (CD19-directed CAR-T cells) inimmune-mediated CNS diseases​

    Principal investigator: Mar Guasp Verdaguer, Yolanda Blanco Morgado.
    Funder: Instituto de Salud Carlos III.
    Code: ICI26/00029.
    Duration: 01/01/2027 - 31/12/2032

  • Antibody profiles against white matter antigens in CNSdemyelinating syndromes: novel reactivities andclinical–immunological correlates​

    Principal investigator: Lidia Sabater Baudet, Maria Sepulveda Gazquez.
    Funder: Instituto de Salud Carlos III.
    Code: PI25/00148.
    Duration: 01/01/2026 - 31/12/2028

  • Impact of transcutaneous cervical spinal cord stimulation on handmobility in patients with MS, particularly progressive forms,assessed using advanced MRI​

    Principal investigator: Sara Llufriu Duran.
    Funder: EME-REEM.
    Duration: 01/01/2026 - 31/12/2026

  • Disability accrual in multiple sclerosis: combined models of damage, repair, and brain and spinal cord reserve using neuroimaging and blood biomarkers

    Principal investigator: Sara Llufriu Duran.
    Funder: Instituto de Salud Carlos III.
    Code: PI24/0056.
    Duration: 01/01/2025 - 31/12/2027

  • Inflammatory Diseases Network. Cooperative Research Network Oriented to Health Outcomes in Inflammatory Diseases (REI)

    Principal investigator: Sara Llufriu Duran.
    Funder: Instituto de Salud Carlos III.
    Code: RD24/0007/0034.
    Duration: 01/01/2025 - 31/12/2027

  • Neuroimaging multi-modal approach to understand mechanisms of tissue DAmage in Multiple sclerosis patients and predictive models (daMoS)

    Principal investigator: Sara Llufriu Duran.
    Funder: Instituto de Salud Carlos III.
    Code: PI21/01189.
    Duration: 01/01/2022 - 31/12/2024

  • Grup d'Imatge Avançada en Malalties Neuroimmunològiques (ImaginEM)

    Principal investigator: Sara Llufriu Duran.
    Funder: Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR).
    Code: 2021-SGR-01325.
    Duration: 01/01/2022 - 31/12/2024

  • COVID-19 vaccination in immunosuppressed patientswith multiple sclerosis​

    Principal investigator: Yolanda Blanco Morgado.
    Funder: La Marató de TV3.
    Duration: 01/01/2021 - 31/12/2023

  • Dendritic cells therapy combined with immunomodulatory treatment in multiple sclerosis

    Principal investigator: Yolanda Blanco.
    Funder: Instituto de Salud Carlos III.
    Code: ICI19/00034.
    Duration: 01/01/2020 - 31/12/2023

  • Taxonomy, Treatment, Targets and Remission (3TR): Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

    Principal investigator: Luis F Quintana Porras, Ricard Cervera Segura, Juan de Dios Canete Crespillo, Maria Azucena Salas Martinez, Yolanda Blanco Morgado.
    Funder: European Commission.
    Code: CE_IMI2-2018-14.
    Duration: 01/09/2019 - 31/08/2026

Major founders

The research of this group can be carried out thanks to the funders.